Yu H - Search Results

1

SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer.

Li K, Shu D, Li H, Lan A, Zhang W, Tan Z, Huang M, Tomasi ML, Jin A, Yu H, Shen M, Liu S. Li K, et al. Among authors: yu h. Cell Death Dis. 2024 Jun 24;15(6):444. doi: 10.1038/s41419-024-06838-9. Cell Death Dis. 2024. PMID: 38914552 Free PMC article.

2

Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.

Qu F, Luo Y, Peng Y, Yu H, Sun L, Liu S, Zeng X. Qu F, et al. Among authors: yu h. Front Immunol. 2024 Jan 11;14:1335546. doi: 10.3389/fimmu.2023.1335546. eCollection 2023. Front Immunol. 2024. PMID: 38274836 Free PMC article.

3

Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.

Tang L, Jiang L, Shu X, Jin Y, Yu H, Liu S. Tang L, et al. Among authors: yu h. Sci Rep. 2024 May 23;14(1):11761. doi: 10.1038/s41598-024-62592-0. Sci Rep. 2024. PMID: 38783028 Free PMC article.

4

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

Shen M, Chen S, Han X, Hao Y, Wang J, Li L, Chen T, Wang B, Zou L, Zhang T, Zhang W, Han X, Wang W, Yu H, Li K, Liu S, Jin A. Shen M, et al. Among authors: yu h. Cancer Immunol Immunother. 2024 Jun 4;73(8):150. doi: 10.1007/s00262-024-03729-y. Cancer Immunol Immunother. 2024. PMID: 38832948 Free PMC article.

5

Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer.

Pu D, Xu Y, Yu H, Yang T, Tang L, Tan W, Zhang W, Liu S. Pu D, et al. Among authors: yu h. Transl Cancer Res. 2024 Aug 31;13(8):4096-4112. doi: 10.21037/tcr-24-505. Epub 2024 Aug 23. Transl Cancer Res. 2024. PMID: 39262459 Free PMC article.

6

Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.

Su K, Peng Y, Yu H. Su K, et al. Among authors: yu h. Dis Markers. 2022 May 29;2022:9141117. doi: 10.1155/2022/9141117. eCollection 2022. Dis Markers. 2022. PMID: 35677632 Free PMC article.

7

tiRNA-Gln-CTG is Involved in the Regulation of Trophoblast Cell Function in Pre-eclampsia and Serves as a Potent Biomarker.

Wang Y, Ji X, Shi H, Liu S, Yu H. Wang Y, et al. Among authors: yu h. Front Biosci (Landmark Ed). 2025 Jan 21;30(1):26345. doi: 10.31083/FBL26345. Front Biosci (Landmark Ed). 2025. PMID: 39862092

8

Retrospective Analysis of the Correlation between Umbilical Blood Flow Index and Maternal and Fetal Outcomes in Pregnant Women with Gestational Diabetes.

Liu Q, Shu S, Zhao X, Yu H. Liu Q, et al. Among authors: yu h. Br J Hosp Med (Lond). 2025 Jan 24;86(1):1-12. doi: 10.12968/hmed.2024.0582. Epub 2025 Jan 24. Br J Hosp Med (Lond). 2025. PMID: 39862042

9

Functional Verification of Differentially Expressed Genes Following DENV2 Infection in Aedes aegypti.

Chen X, Zhou X, Xie X, Li B, Zhao T, Yu H, Xing D, Wu J, Li C. Chen X, et al. Among authors: yu h. Viruses. 2025 Jan 6;17(1):67. doi: 10.3390/v17010067. Viruses. 2025. PMID: 39861856

10

Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research.

Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z, Yu H. Gao Y, et al. Among authors: yu h. Pharmaceutics. 2025 Jan 3;17(1):56. doi: 10.3390/pharmaceutics17010056. Pharmaceutics. 2025. PMID: 39861704 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,702 results

Search Page

Filters